Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02999906
Status:
WITHDRAWN
Last Update Posted:
2017-11-01
First Post:
2016-12-19
Brief Title:
Study to Compare Triple Therapy Oral Treprostinil Ambrisentan and Tadalafil With Dual Therapy Ambrisentan Tadalafil and Placebo in Subjects With Pulmonary Arterial Hypertension
Sponsor:
United Therapeutics
Organization:
United Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06
Completion Date Type:
ESTIMATED
First Submit Date:
2016-12-19
First Submit QC Date:
December 19 2016
Study First Post Date:
2016-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-31
Last Update Post Date:
2017-11-01
Last Update Post Date Type:
ACTUAL